ADRXADARx Pharmaceuticals, Inc.
Earnings
When ADARx Pharmaceuticals, Inc. reports, what it reported each quarter, and how the stock took the results.
6 quarters. Mar 31, 2025 to Sep 30, 2026. USD.
Latest results
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 12, 2026 · after-hours | Nov 12, 2026 | 43 d | 10-Q | $2.22M | +42.6% | -$1.74 | — | |
| Q2 2026 | Jun 30, 2026 | — | — | — | — | — | — | — | — | |
| Q1 2026 | Mar 31, 2026 | — | — | — | — | — | — | — | — | |
| FY 2025 | ||||||||||
| Q3 2025 | Sep 30, 2025 | — | — | — | — | $1.56M | — | -$1.85 | — | |
| Q2 2025 | Jun 30, 2025 | — | — | — | — | — | — | — | — | |
| Q1 2025 | Mar 31, 2025 | — | — | — | — | — | — | — | — | |
Source filings
10-QNov 12, 2026458444
Provenance
ProvenanceData status and checks
ADARx Pharmaceuticals, Inc. · CIK 1802369 · Engraved from SEC EDGAR